Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 16Unknown 11Not yet recruiting 3Withdrawn 2Terminated 2Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Uterine Cervical Neoplasms 4Breast Neoplasms 4Stomach Neoplasms 2Rectal Neoplasms 2Pancreatic Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Triple Negative Breast Neoplasms 1Peritoneal Neoplasms 1Neoplastic Cells, Circulating 1Neoplasms 1Neoplasm, Residual 1Nasopharyngeal Carcinoma 1NSCLC 1Melanoma 1HER2 Negative Breast Cancer 1Carcinoma, Ovarian Epithelial 1

Interventions

Oxaliplatin 13Bevacizumab 11Capecitabine 10Fluorouracil 8Blood Specimen Collection 8Leucovorin 7Cetuximab 7Folfox protocol 6pembrolizumab 5Drug Therapy 5trifluridine tipiracil drug combination 4dostarlimab 4Nivolumab 4Irinotecan 4HMPL-013 4fludarabine 3XELOX 3Specimen Handling 3IFL protocol 3Cyclophosphamide 3Biopsy 3toripalimab 2tislelizumab 2tipiracil 2regorafenib 2pertuzumab 2envafolimab 2encorafenib 2cemiplimab 2atezolizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Colonic Neoplasms × Chemotherapy, Adjuvant × Clear all
NCT06609551 2024-09-24

ZJCH-CRCC-1

Zhejiang Cancer Hospital

Phase 3 Recruiting
312 enrolled
Gastrointestinal

Colonic Neoplasms

NCT05194878 2022-01-18

Neoadjuvant FOLFOXIRI Versus Immediate Surgery for Stage II and III Colon Cancers

Sun Yat-sen University

Phase 3 Recruiting
840 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡